Johns Hopkins University at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Johns Hopkins University brings 24 presentations to ObesityWeek 2026 in National Harbor. Its program leans toward children and adolescents, covering eating behavior, brain development and GLP-1 drug use in young patients, including semaglutide in adolescents with autism. It also addresses obesity treatment for adults with serious mental illness, such as GLP-1 drug versus metformin prescribing alongside antipsychotics.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Johns Hopkins University Baltimore, MD | |
Private research university in Baltimore with schools of medicine, nursing and public health. | Poster Sat Nov 14 7:30pm–8:30pm Attention-Related Difficulties, Irregular Eating, and Inflammation: Evidence From NHANES Neuroscience of appetite and eating Poster Sat Nov 14 7:30pm–8:30pm Role of FHL1 in Human Adipocyte Development Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Age-Invariant and Age-Evolving Relationships of Child BMIz With Regional Brain Volume From Infancy Through Adolescence Neuroscience of appetite and eating Poster Sat Nov 14 7:30pm–8:30pm Home Food Environment and Delay Discounting Moderate Appetite Effects on Eating and Weight in Children Neuroscience of appetite and eatingNutrition, diet and food Poster Sat Nov 14 7:30pm–8:30pm Severe Obesity is Associated with Symptom Burden Despite Normal Cardiac Structure in Adolescents Metabolism and integrative physiology Session Sun Nov 15 8:30am–9:30am Session Sun Nov 15 9:30am–10:30am Session Sun Nov 15 10:30am–11:30am The Missing Link in Obesity Care - Building Resilient Habits for a Chaotic World Looks at weaving lifestyle medicine, from sleep and stress to social connection, into routine obesity care so motivated patients can sustain their changes. Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Semaglutide and Tirzepatide Dose Escalation Trajectories and Treatment Utilization Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Real-World Effectiveness of Semaglutide and Tirzepatide Vs Metformin for Adults With Obesity on Antipsychotics Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Eating Control and Food Cravings After Transition from Injectable Incretin Therapy to Orforglipron Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Characteristics Associated with GLP-1 RA vs. Metformin Prescribing in Adults Receiving Antipsychotics Clinical obesity care and professional practiceObesity pharmacotherapy and drug development Talk Sun Nov 15 5:00pm–5:10pm Wearable-Derived Physical Activity Patterns in Preclinical and Clinical Obesity Metabolism and integrative physiologyObesity pharmacotherapy and drug developmentPediatric and adolescent obesityBariatric surgery and devicesNutrition, diet and foodInterventional and clinical studies Talk Sun Nov 15 6:30pm–8:00pm One Patient, Many Perspectives: A Multidisciplinary Expert Roundtable on Obesity Care Specialists from primary care, cardiology, sleep medicine, surgery and other fields discuss one shared patient case to show how coordinated obesity care works. Metabolism and integrative physiologyInterventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceChronic disease and obesity complications Talk Mon Nov 16 8:30am–8:45am Maternal Obesity and Neurobehavioral Circuits in Offspring Metabolism and integrative physiologyNeuroscience of appetite and eatingPediatric and adolescent obesity Talk Mon Nov 16 9:00am–9:10am Implications of the LEAP Trial for Clinical Practice Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthObesity pharmacotherapy and drug developmentChronic disease and obesity complications Poster Mon Nov 16 2:30pm–3:30pm GLP-1 Receptor Agonist Safely Decreases Weight Percentiles in a 2 Year Old Child With Severe Obesity Pediatric and adolescent obesity Poster Mon Nov 16 2:30pm–3:30pm Case Series: Semaglutide Use in Adolescents With Autism Improves Food Seeking and Aggressive Behaviors Pediatric and adolescent obesity Poster Mon Nov 16 2:30pm–3:30pm Poster Mon Nov 16 2:30pm–3:30pm Caregiver Perspectives on Telemedicine in an Urban Pediatric Obesity Clinic: A Post-Pandemic Review Pediatric and adolescent obesityObesity pharmacotherapy and drug development Talk Mon Nov 16 5:00pm–6:30pm Pediatric Weight Management Clinical obesity care and professional practiceNutrition, diet and foodChronic disease and obesity complicationsPediatric and adolescent obesityObesity pharmacotherapy and drug development Session Tue Nov 17 10:00am–11:00am Translating and Disseminating a Behavioral Obesity Treatment Intervention for Adults with Serious Mental Illness Shares ACHIEVE trial results on behavioral obesity treatment for adults with serious mental illness and how community mental health partners help apply them. Interventional and clinical studiesClinical obesity care and professional practicePolicy and public health Talk Tue Nov 17 10:00am–10:40am Discussion of Methods and Results From ACHIEVE Trial Interventional and clinical studiesClinical obesity care and professional practicePolicy and public health Talk Tue Nov 17 10:00am–10:15am How Changes to SNAP Benefits and Eligibility Affect Participant Health and Wellbeing Policy and public healthNutrition, diet and foodPediatric and adolescent obesityPopulation health and epidemiology |
Find decision makers at Johns Hopkins University
Tell us what you sell and we’ll find the people at Johns Hopkins University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction